Literature DB >> 12189243

Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12.

Burkhard Becher1, Brigit G Durell, Randolph J Noelle.   

Abstract

IL-12 is considered a critical proinflammatory cytokine for autoimmune diseases such as multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis (EAE). IL-12 is a heterodimer composed of a p35 subunit and a common p40 subunit shared by other cytokines. Both IL-12 p40(-/-) and p35(-/-) mice fail to produce IL-12 p70 heterodimer. However, in contrast to p40(-/-) mice, p35(-/-) mice are highly susceptible to the induction of EAE, establishing that IL-12 p70 is not essential for the development of EAE. When compared with wild-type mice, both p40(-/-) and p35(-/-) mice show deficiencies in primary IFN-gamma responses by lymph node cells. Expression profiling of the inflamed CNS revealed that Th2 cytokines such as IL-4 and IL-10 are upregulated in p35(-/-) mice, whereas LT-alpha and TNF-alpha levels are reduced. These studies show that a molecule other than IL-12 p70, which uses the p40 subunit, fulfills the functions previously attributed to IL-12 with regard to the development and pathogenesis of this autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12189243      PMCID: PMC150420          DOI: 10.1172/JCI15751

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

Review 1.  Interleukin-12, a key cytokine in Th1-mediated autoimmune diseases.

Authors:  L Adorini
Journal:  Cell Mol Life Sci       Date:  1999-09       Impact factor: 9.261

2.  IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines.

Authors:  E H Tran; E N Prince; T Owens
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

Review 3.  Interferon beta in multiple sclerosis: is IL-12 suppression the key?

Authors:  C L Karp; C A Biron; D N Irani
Journal:  Immunol Today       Date:  2000-01

Review 4.  The critical role of IL-12 and the IL-12R beta 2 subunit in the generation of pathogenic autoreactive Th1 cells.

Authors:  E M Shevach; J T Chang; B M Segal
Journal:  Springer Semin Immunopathol       Date:  1999

Review 5.  Interleukin-12: a cytokine at the interface of inflammation and immunity.

Authors:  G Trinchieri
Journal:  Adv Immunol       Date:  1998       Impact factor: 3.543

Review 6.  The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses.

Authors:  M K Gately; L M Renzetti; J Magram; A S Stern; L Adorini; U Gubler; D H Presky
Journal:  Annu Rev Immunol       Date:  1998       Impact factor: 28.527

7.  Alloantigen-reactive Th1 development in IL-12-deficient mice.

Authors:  J R Piccotti; K Li; S Y Chan; J Ferrante; J Magram; E J Eichwald; D K Bishop
Journal:  J Immunol       Date:  1998-02-01       Impact factor: 5.422

8.  Characterization of mouse interleukin-12 p40 homodimer binding to the interleukin-12 receptor subunits.

Authors:  X Wang; V L Wilkinson; F J Podlaski; C Wu; A S Stern; D H Presky; J Magram
Journal:  Eur J Immunol       Date:  1999-06       Impact factor: 5.532

9.  Treatment with homodimeric interleukin-12 (IL-12) p40 protects mice from IL-12-dependent shock but not from tumor necrosis factor alpha-dependent shock.

Authors:  F Mattner; L Ozmen; F J Podlaski; V L Wilkinson; D H Presky; M K Gately; G Alber
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

10.  Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans.

Authors:  K Decken; G Köhler; K Palmer-Lehmann; A Wunderlin; F Mattner; J Magram; M K Gately; G Alber
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

View more
  153 in total

1.  RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation.

Authors:  Laura Codarri; Gabor Gyülvészi; Vinko Tosevski; Lysann Hesske; Adriano Fontana; Laurent Magnenat; Tobias Suter; Burkhard Becher
Journal:  Nat Immunol       Date:  2011-04-24       Impact factor: 25.606

Review 2.  Concordance of preclinical and clinical pharmacology and toxicology of monoclonal antibodies and fusion proteins: soluble targets.

Authors:  Pauline L Martin; Peter J Bugelski
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

Review 3.  Averting inflammation by targeting the cytokine environment.

Authors:  Manfred Kopf; Martin F Bachmann; Benjamin J Marsland
Journal:  Nat Rev Drug Discov       Date:  2010-09       Impact factor: 84.694

Review 4.  T-cell based immunotherapy in experimental autoimmune encephalomyelitis and multiple sclerosis.

Authors:  Kate O'Brien; Bruno Gran; Abdolmohamad Rostami
Journal:  Immunotherapy       Date:  2010-01       Impact factor: 4.196

Review 5.  Mechanisms regulating regional localization of inflammation during CNS autoimmunity.

Authors:  Emily Pierson; Sarah B Simmons; Luca Castelli; Joan M Goverman
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

Review 6.  Neuroimmunotherapies Targeting T Cells: From Pathophysiology to Therapeutic Applications.

Authors:  Stefan Bittner; Heinz Wiendl
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

7.  Towards common denominators in primary biliary cirrhosis: the role of IL-12.

Authors:  Ana Lleo; M Eric Gershwin; Alberto Mantovani; Pietro Invernizzi
Journal:  J Hepatol       Date:  2011-10-15       Impact factor: 25.083

8.  IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice.

Authors:  Stefan Haak; Andrew L Croxford; Katharina Kreymborg; Frank L Heppner; Sandrine Pouly; Burkhard Becher; Ari Waisman
Journal:  J Clin Invest       Date:  2008-12-15       Impact factor: 14.808

9.  Microglial expression of the B7 family member B7 homolog 1 confers strong immune inhibition: implications for immune responses and autoimmunity in the CNS.

Authors:  Tim Magnus; Bettina Schreiner; Thomas Korn; Carolyn Jack; Hong Guo; Jack Antel; Igal Ifergan; Lieping Chen; Felix Bischof; Amit Bar-Or; Heinz Wiendl
Journal:  J Neurosci       Date:  2005-03-09       Impact factor: 6.167

Review 10.  APC-derived cytokines and T cell polarization in autoimmune inflammation.

Authors:  Ilona Gutcher; Burkhard Becher
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.